Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|January 6, 2001
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritisA M Bendele, E S Chlipala, J Scherrer, et al.
Clinical and Experimental Rheumatology|November 2, 1999
Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Osteoarthritis and Cartilage|May 18, 2005
Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritisE E Moore, A M Bendele, D L Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389A M Bendele, K J Ruterbories, S M Spaethe, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 24, 1999
Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic ratsA M Bendele, J McComb, T Gould, et al.
Immunopharmacology and Immunotoxicology|January 1, 1989
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic interventionL D Butler, K M Mohler, N K Layman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritisA M Bendele, D N Benslay, J T Hom, et al.
Arthritis and Rheumatism|May 1, 1997
Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the kneeA C Bakker, L A Joosten, O J Arntz, et al.
Clinical Immunology and Immunopathology|December 1, 1989
Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic interventionL D Butler, N K Layman, R L Cain, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studiesS A Silbaugh, P W Stengel, S L Cockerham, et al.
Pageof 6